|
DE2059922A1
(de)
*
|
1970-12-05 |
1972-06-15 |
Boehringer Mannheim Gmbh |
Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
|
|
DE2244328A1
(de)
*
|
1972-09-09 |
1974-03-21 |
Boehringer Mannheim Gmbh |
Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
|
|
US4388308A
(en)
*
|
1980-06-09 |
1983-06-14 |
G.D. Searle & Co. |
N6 -[(2-Hydroxypropyl)aryl]adenosines
|
|
CA1239397A
(en)
*
|
1983-08-01 |
1988-07-19 |
James A. Bristol |
N.sup.6-substituted adenosines
|
|
DE3576344D1
(de)
*
|
1984-04-18 |
1990-04-12 |
Whitby Research Inc |
Cardio-vasodilatatore n-6-substituierte adenosine.
|
|
US5310731A
(en)
*
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
|
US5284834A
(en)
*
|
1985-03-29 |
1994-02-08 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
|
|
US5066655A
(en)
*
|
1987-04-24 |
1991-11-19 |
Whitby Research, Inc. |
N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
|
|
US5565566A
(en)
*
|
1987-04-24 |
1996-10-15 |
Discovery Therapeutics, Inc. |
N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
|
|
US5030624A
(en)
*
|
1988-10-26 |
1991-07-09 |
G. D. Searle & Co. |
R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
|
|
US5032584A
(en)
*
|
1988-10-26 |
1991-07-16 |
G. D. Searle & Co. |
S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
|
|
US4992535A
(en)
*
|
1988-10-26 |
1991-02-12 |
G. D. Searle & Co. |
Methods of making novel R and S diastereomers of N6 -[(2-hydroxypropyl)aryl]adenosines
|
|
US5256650A
(en)
*
|
1989-03-29 |
1993-10-26 |
Merrell Dow Pharmaceuticals Inc. |
Selective adenosine receptor agents
|
|
ZA902280B
(en)
*
|
1989-03-29 |
1990-12-28 |
Merrell Dow Pharma |
Selective adenosine receptor agents
|
|
US5391739A
(en)
*
|
1989-03-29 |
1995-02-21 |
Merrell Dow Pharmaceuticals Inc. |
Selective adenosine receptor agents
|
|
US5561134A
(en)
*
|
1990-09-25 |
1996-10-01 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
|
EP0550631B1
(en)
*
|
1990-09-25 |
1997-01-02 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Compounds having antihypertensive and anti-ischemic properties
|
|
DK62692D0
(xx)
*
|
1992-05-14 |
1992-05-14 |
Novo Nordisk As |
|
|
DK62592D0
(xx)
*
|
1992-05-14 |
1992-05-14 |
Novo Nordisk As |
|
|
US5672588A
(en)
*
|
1992-05-20 |
1997-09-30 |
Novo Nordisk A/S |
Purine derivatives
|
|
AU4772493A
(en)
*
|
1992-07-15 |
1994-02-14 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Sulfo-derivatives of adenosine
|
|
US6784165B1
(en)
*
|
1999-11-23 |
2004-08-31 |
Aderis Pharmaceuticals, Inc. |
Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
|
|
MXPA05011428A
(es)
*
|
2003-04-24 |
2006-05-31 |
Aderis Pharmaceuticals Inc |
Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
|
|
US20050118262A1
(en)
*
|
2003-09-17 |
2005-06-02 |
Jack Aurora |
Controlled release formulation
|
|
JP2013513551A
(ja)
*
|
2009-12-10 |
2013-04-22 |
中国医学科学院葯物研究所 |
Ｎ６−置換アデノシン誘導体とｎ６−置換アデニン誘導体の鎮静、催眠，抗うつ，抗痙攣，抗てんかん，抗パーキンソン病と認知証予防・治療の用途
|